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Abstract
The hypothesis that deracemization of racemic ibuprofen (IBU) occurs via the enolization
of a Candida rugosa lipase (CRL)-ibuprofen ester (Scheme 1.6.2) was disproven by reacting
racemic IBU under the conditions that were used to deracemize ibuprofen methyl ester (IME),
namely pH 7.6. At pH 7.6, IME through IBU butyl esters were not formed in-situ and racemic
IBU was not deracemized by reacting the corresponding primary alcohol with racemic IBU in the
presence of CRL.
At pH 7.6, hexyl through dodecyl IBU esters were formed in-situ by reacting the
corresponding primary alcohol with racemic IBU in the presence of CRL. The longer chain
alcohols reacted faster following the trend: hexanol, octanol, decanol, and dodecanol with values
9.0 x 10-4, 2.3 x 10-3, 3.9 x 10-3, and 6.4 x 10-3 hr-1, respectively.
Initially it was believed that the formation of ester corresponded with an increase of (R)IBU but after isolating (R)-IBU and IBU dodecyl ester, in a corresponding 48 and 45 % respective
yield, it was determined that the monitoring of the reactions by chiral HPLC was affected by the
difficulties in recovering the ester. The esters formed are therefore probably only of (S)-IBU.
Molecular docking studies indicated that IBU through IBU propyl esters enter the
hydrophobic pocket of CRL, isobutyl group first. However, longer chain IBU esters bind with the
primary alkyl group in the hydrophobic pocket first.
In addition, lower concentrations of the substrates, not using 4-(2-hydroxyethyl)-1piperazineethanesulfonic acid (HEPES) buffer, using the CRL supernatant versus the whole
commercial enzyme, and reacting at pH 6.0 versus 7.6 all led to faster reactions of racemic IBU
and dodecanol.
For the reaction of racemic IBU and n-butanol catalyzed by CRL, formation of ester was
favored at pH 6.0 and hydrolysis of the same ester was favored at pH 7.6. The hydrolysis of larger
chain IBU esters was much slower. The observed slower hydrolysis is due to the hydrophobic
anchoring of the primary alkyl group of long chain IBU esters in the hydrophobic pocket of CRL.
vi
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Chapter 1: Introduction
1.1 Enantiomers
Enantiomers are asymmetric (chiral) mirror-image compounds. Many pharmaceuticals are
chiral but are sold as equal mixtures of enantiomers called a racemic mixture or racemate.
Enantiomers have identical physical and chemical properties in symmetric environments,
therefore, racemic mixtures are difficult to separate.
In asymmetric environments such as biological systems, enantiomers have different
activities.1,2 There are many examples where one enantiomer of a racemic pair exhibits the
medicinal activity of a drug, while the other enantiomer lacks the activity or has harmful side
effects.3 An example is the sedative thalidomide, which was sold in many countries around the
world from 1957-1961. Thalidomide was removed from retail when it was found to cause birth
defects. (R)-thalidomide caused the sedative effects, while (S)-thalidomide caused birth defects.4
1.2 Ibuprofen
Ibuprofen (IBU) is one of the most common non-steroidal anti-inflammatory drugs
(NSAID) consumed today for treatment of headaches, fever, muscle, and joint pain. It is part of
a family of 2-arylpropionic acids or profens such as naproxen and ketoprofen. In the United
States, it has long been sold as a racemic mixture. For example, the synthesis of racemic IBU
using an aryl-1,2-translocation rearrangement was developed by Shandong Xinhua
Pharmaceutical Company.5 The six-step process is shown in Scheme 1.1.
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Scheme 1.1 The Flow Chart of Racemic IBU Synthesis using Aryl-1,2-Translocation
Rearrangement5
Although this method of producing racemic IBU is effective at an industrial scale, the
production of enantiopure IBU has been inadequate due to the difficulties of separating the
enantiomers of a racemic mixture.6 Therefore, the development of new separation methods for
racemic IBU remains a large area of pharmaceutical research.7 Efforts have been made to stereospecifically and enzymatically-catalyze the resolution of IBU enantiomers.8 In addition, enzyme
catalysis offers a more environmentally benign synthesis with enantio-, chemo- or
regioselectivities.9 Subsequently, a number of enzymatic processes have been developed on an
industrial scale.10 In profen synthesis, substantial work has been demonstrated in the biocatalysis
industry with different types of enzymes and reactions as shown in Scheme 1.2.
The function of NSAID’s is hindering the cyclooxygenase (COX) pathway by the
inhibition of prostaglandin synthesis.11 The (S)-enantiomer of IBU is more effective at inhibiting
COX than the (R)-enantiomer.12 The (R)-enantiomer also produces undesired effects in the
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gastrointestinal tract (GIT), lipid metabolism, and membrane function.13 For these reasons, (S)IBU has greater value than racemic IBU.

Scheme 1.2 Diverse Biocatalytic Reactions for the Separation of Profen Enantiomers14
1.3 Lipase
Lipase are biocatalysts in organic synthesis that catalyze Kinetic Resolution (KR)
reactions.15 They are found in bacteria, fungi, plants and animals that function by
hydrophobic/hydrophilic interfacial activation preceding to an increase in hydrolytic activity. 16
They hydrolyze triglycerides into fatty acids and glycerol. Their application ranges from
detergents, foods, pulp/paper, and catalysts in industry.17 They are widely used due to their
commercial availability, low cost, not requiring a cofactor, catalysis in both aqueous and nonaqueous solvents, and recoverability.18
3

They also have broad substrate spectra, high activities and perform adequately in organic
synthesis, including the resolution of racemic mixtures of compounds.19 Among their advantages
is their stereoselectivity in synthesis involving the resolution of racemates.20 Numerous lipase
reactions involve the asymmetrization of prochiral and meso-diols or the Dynamic Kinetic
Resolution (DKR) of racemic primary and secondary alcohols via enzyme-catalyzed acyl
transfer.21 It has been observed that the enantio-preference of an enzyme is not reversed when an
organic solvent substitutes water because, in terms of equilibrium, hydrolysis and esterification
are reactions in opposite directions.22
Lipase have a common catalytic triad active site consisting of a serine, histidine, and
aspartic/glutamic acid which assists serine to attack an acyl donor, hence, they can also be referred
to as serine hydrolase.23 The tandem deprotonation of the serine hydroxyl group by the imidazole
of histidine in coordination with the aspartate/glutamate carboxyl groups is a charge relay network
that makes the hydroxyl oxygen more nucleophilic.24
In addition, up to four hydrogen bonds with other enzyme residues increase the catalytic
activity of the lipase. These hydrogen bonds are essential for diastereomeric discrimination of
racemic substrates.25 Thus, the enantiomeric preference of a lipase relies in the substrate’s
esterification/hydrolysis mechanism as shown in Scheme 1.3 as well as the entire shape of the
enzyme pocket.
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Scheme 1.3 Literature Mechanism of Lipase Catalyzed Esterification and Hydrolysis26
The mechanism shown in Scheme 1.3 is a two-step reaction which requires two incoming
substrates. In the first step, serine is acylated with the carboxyl group of the acyl donor
(Substrate 1) via enzyme substrate addition (E + S) and through a tetrahedral intermediate
(EP*) releases an alcohol or water molecule forming an acyl-enzyme (ES) complex. In the
second step, deacylation of the ES complex is caused by an attack of a hydroxyl group in the
nucleophile (Substrate 2), which can be water or an alcohol. The formation of a second EP*,
gives the free enzyme (E) and the acyl product (P). In KR reactions of alcohols, the second EP*
is imperative because the alcohol replaces Substrate 2 in the formation of the EP* complex.26
Thus, the formation and collapse of the intermediate complex ES and EP* determines the
stereoselectivity of lipase-catalysed hydrolysis.27
5

1.4 Kinetic Resolution (KR) of IBU Enantiomers
Since the separation of racemic mixtures is difficult, the discovery of enzyme catalyzed
KR of enantiomers is a method of separating them.28 For instance, Candida rugosa lipase (CRL)
has been used to enantioselectively esterify racemic IBU29 and hydrolyze racemic IBU esters.30
From the work of Chavez et. al.27, an enantioselective esterification of racemic IBU, followed by
the separation of unreacted (R)-IBU from the (S)-IBU alkyl ester and subsequent hydrolysis of the
(S)-IBU ester, successfully separated pure (S)-IBU in a 46 out of a 50 % possible yield from
racemic IBU (Scheme 1.4).

Scheme 1.4 KR of (S)-IBU via Enantioselective Esterification and Hydrolysis with CRL27
Following Le Chatelier’s principle for these KR reactions, it was observed that
esterification was preferred in a non-polar solvent (cyclohexane) whereas hydrolysis was preferred
in a polar solvent (water). The Enantiomeric Ratio (E) was almost 3 times higher for the formation
of the decyl versus butyl esters, i.e., 130 vs 46, respectively, which means that longer chains have
higher selectivity for the formation of (S)-IBU esters. Overall, the resolution of the decyl ester
was better as it allowed for a more facile separation of the (S)-IBU decyl ester from unreacted (R)IBU. The only drawback of the decyl system was that (S)-IBU decyl ester took 96 hours to
hydrolyze versus 48 hours in the butyl system.
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1.5 Dynamic Kinetic Resolution (DKR) of Racemic IBU
In the process of learning how to enzymatically resolve IBU enantiomers, Chavez et. al.31
discovered that (R)-IBU can be converted to (S)-IBU in a two-step process (Scheme 1.5) and
therefore eliminate the waste usually associated with only separating enantiomers. The first step
was to form racemic IBU methyl ester (IME) by Fischer esterification followed by hydrolysis of
this ester with CRL in a high pH buffer and co-solvent dimethylsulfoxide (DMSO) to help
solubilize IME. The overall result was the isolation of 88 % pure (S)-IBU from racemic IBU.

Scheme 1.5 Conversion of Racemic IME to (S)-IBU31
The proposed mechanism for this DKR was the in-situ base catalyzed equilibration of IME
enantiomers followed by the known preference for hydrolysis of (S)-IME catalyzed by CRL as
outlined in Scheme 1.5.1.

Scheme 1.5.1 First Proposed Mechanism of DKR of Racemic IME31
1.6 Isomerase Activity of CRL
However, Mortazavi et. al.8 observed that commercial CRL powder in lactose is acidic and
therefore the optimal pH for the DKR of racemic IME is 7.6. In addition, N, N-dimethylformamide

7

(DMF) was found to be a better co-solvent than the DMSO co-solvent used in previous work
(Scheme 1.6).

Scheme 1.6 Optimized Conversion of Racemic IME to (S)-IBU8
Because racemization of (R)-IME without CRL was not observed at pH 7.6 (Scheme 1.6.1),
the previous enolization hypothesis was ruled out, and a new CRL isomerase mechanism was
proposed.

Scheme 1.6.1 Attempted Racemization of (R)-IME without CRL8
Since the mechanism of the observed DKR of racemic IME requires CRL and an acylenzyme intermediate that was hypothesized to form at the active site of serine hydrolase for both
enzyme catalyzed esterifications and hydrolysis reactions, a second hypothesis for how this
reaction occurred was proposed (Scheme 1.6.2).

8

Scheme 1.6.2 Second Proposed Mechanism of DKR of Racemic IME8
The proposed mechanism begins with the formation of racemic-IBU enzyme ester,
followed by deprotonation of the chiral center at the alpha position of the (R)-IBU enzyme ester
by the nearby histidine (pKa 6.0) of the catalytic triad. Re-protonation of the enolate intermediate
to form (S)-IBU enzyme ester and subsequent hydrolysis was used to explain the deracemization
of racemic IBU to mostly (S)-IBU.
Because Scheme 1.3 indicates that the (R)-IBU enzyme ester could be formed without
starting from racemic IME, the initial goal of this research was to determine if (S)-IBU could be
synthesized by reacting racemic IBU with CRL at pH 7.6. If this occurred, the conversion of
racemic IBU could be accomplished without having to synthesize its methyl ester, making the
whole deracemization process more efficient.

9

Chapter 2: Results and Discussion
2.1 Isolation of Racemic IBU from Commercial Tablets
Generic over the counter 200 mg IBU tablets purchased from Sam’s Club were immersed
in acetone to separate racemic IBU from the coating and fillers of the tablets. Once the tablets
were swollen with acetone, IBU was released by piercing the tablets with a spatula. Vacuum
filtration with a Buchner funnel was performed to separate the IBU acetone solution from the
insoluble material. The IBU solution was then transferred to a round bottom flask and the acetone
was evaporated under reduced pressure using a rotary evaporator to give a quantitative yield of
racemic IBU (i.e., 4 g from 20 pills).
2.2 Reaction of Racemic IBU and CRL
To test if the mechanism postulated by Mortazavi et. al.8 (Scheme 1.6.2) was valid,
racemic IBU was reacted under the same conditions that were used to deracemize racemic IME
(Scheme 2.1). DMF was omitted since racemic IME was not introduced in the reaction.

Scheme 2.1 Reaction of Racemic IBU with CRL and HEPES Buffer at pH 7.6
If deracemization occurred by enolizing an IBU-enzyme ester, then IME is not required as
the enzyme ester is an intermediate in CRL mediated reactions (Scheme 1.3). However, no
deracemization was detected by chiral phase HPLC (Chromatograms 2.1) when racemic IBU was
reacted with CRL, thus implying that an ester is required to achieve deracemization.
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(S)
50%

30 hr

(S)
50%

77 hr

(R)
50%

(R)
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(S)
50%

(S)
50%

Chromatograms 2.1 Reaction of Racemic IBU with CRL and HEPES Buffer at pH 7.6
2.3 Reaction of Racemic IBU, Methanol, and CRL
Since CRL catalyzes the formation of esters as well as their hydrolysis, depending upon
the solvent used,32 and racemic IME can be converted to (S)-IBU with CRL under controlled
conditions (Scheme 1.6), in-situ formation of IME was attempted to see if deracemization was
possible without having to first perform a Fischer esterification. Racemic IBU and methanol in
different ratios were reacted with CRL under the same conditions as racemic IME (Scheme 2.2).

Scheme 2.2 Reactions of Racemic IBU, Methanol, and CRL with HEPES Buffer at pH 7.6
Nevertheless, no esterification with methanol as a co-reactant or deracemization of racemic
IBU was observed because Chromatograms 2.2 shows no ester peaks and a 50/50 mixture of IBU.
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50%

(S)
50%

72 hr
2eq MeOH

72 hr
4eq MeOH

(R)
50%

(R)
50%

(S)
50%

(S)
50%

Chromatograms 2.2 Reactions of Racemic IBU, Methanol, and CRL
2.4 Reactions of CRL with Racemic IBU and Different Chain Length Primary Alcohols with
HEPES Buffer at pH 7.6
2.4.1 Hypothesis of the Reactions of CRL with Racemic IBU and Different Chain Length
Primary Alcohols with HEPES Buffer at pH 7.6
Since the native solvent of CRL is water and its initial use was to hydrolyze esters, nonpolar solvents such as cyclohexane33 have been used to drive the equilibrium towards forming
esters of (S)-IBU with high enantioselectivity with water as a byproduct.
Although esterification of racemic IBU with methanol in water was not observed, it was
hypothesized that because CRL has a hydrophobic pocket to bind long chain fatty acids, perhaps
IBU esters could be formed in-situ with long chain primary alcohols in water and that an inversion
of configuration from (R) to (S)-IBU ester followed by hydrolysis of (S)-IBU ester would produce
(S)-IBU just as racemic IME was converted to (S)-IBU (Scheme 2.3).
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Scheme 2.3 Hypothesized Deracemization of Racemic IBU with Different Chain Length
Alcohols using CRL and HEPES Buffer at pH 7.6
2.4.2 Analysis of Racemic IBU, Different Chain Length Alcohols, and CRL with HEPES
Buffer at pH 7.6
From the work of Mortazavi et. al.8, these reactions were maintained at pH 7.6 using a
HEPES buffer by adding drops of 1 M NaOH or HCl and were kept at a constant temperature of
40oC in a sand bath with a transformer while stirring. For the analysis of the IBU esters, aliquots
of the reaction were acidified to a pH of ~ 5 using 1M HCl and then extracted with hexanes to be
injected into a chiral column HPLC. The solvent used to carry the sample through the HPLC
Chiracel OJ-column was 3 % isopropanol in hexanes. Injections were performed to separate (R)
and (S)-enantiomers of IBU to gradually see a decrease of the (S)-IBU peak as an IBU ester was
formed.
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2.4.3 Results of Reactions of Racemic IBU, Different Chain Length Alcohols, and CRL with
HEPES Buffer at pH 7.6
These reactions were performed to test whether increasing the chain length of the alcohol
would alter the preference of ester formed in-situ and in the same reaction, hydrolysis of the
preferred ester would lead to the formation of more than 50 % (S)-IBU.
However, ester formation was only observed for chain lengths 6, 8, 10, and 12 as peaks
eluding before the IBU enantiomers. In these cases, the percentage of (S)-IBU always decreased
with an apparent increase of (R)-IBU as the chain length increased, shown in Chromatograms 2.3.
210 hr

(R)
50%

207 hr

(S)
50%

n=2

218 hr
n=4

154 hr

(R)
50%

(S)
50%

n=3

158 hr
(R)
50%

(R)
49%

(S)
50%
7%

(R)
58%

150 hr

(S)
25%

17%
16%

n=8
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(S)
43%
n=6

(R)
63%

(S)
21%
n = 10

152 hr
n = 12

(R)
68%

(S)
25%

152 hr
n = 16

(R)
50%

(S)
49%

7%
1%

Chromatograms 2.3 Deracemization of Racemic IBU to (R)-IBU with Different Chain
Length Alcohols (H(CH2)nOH) using CRL and HEPES Buffer at pH 7.6
From these chromatograms, the rate of deracemization was measured as a function of
alcohol chain length with a particular interest in the difference in the rate of even numbered
carbons. Also, by comparing the rate of esterification of each ester formed in terms of their chain
length, their enantiomeric preference of ester formed in solution was determined. Although the
equilibrium to form ester is unfavorable in water, chiral IBU esters were formed in-situ to allow
deracemization to occur as was observed for racemic IME. These percentages can be plotted as
(R)-IBU as a function of time (Chart 2.1) to determine the rate of esterification of (S)-IBU with
increasing chain length (Chart 2.2).
Chart 2.1 Long Chain Length IBU Esters formed in-situ with CRL and HEPES Buffer at
pH 7.6
Hexyl Ester

Octyl Ester

Decyl Ester

Dodecyl Ester

Hexadecyl Ester

75
70

% (R)-IBU

65
60
55
50
45
0

50

100

Time (hrs)

15

150

200

Chart 2.1 illustrates the percentages of (R)-IBU formed as a function of time obtained from
HPLC chromatograms. Firstly, this chart indicates that shorter chain length alcohols (methanol to
butanol) do not form observable amounts of IBU esters in water. Secondly, longer chain length
even numbered alcohols (hexanol to dodecanol) do form observable amounts of IBU esters that
elude before the IBU enantiomers in all HPLC chromatographs. Though tetradecanol (myristyl
alcohol) was not available to test, hexadecanol (cetyl alcohol) did not seem to react at all because
it was insoluble in water.
Other aspects to note were the apparent increase in % (R)-IBU with longer chain length
alcohols, up to a point, and the observation that with longer chains, deracemization appeared to be
favored in the opposite direction than deracemization of IME, (S)-IBU appeared to be converted
to (R)-IBU.
Chart 2.2 Rates of Esterification of Long Chain Length IBU Esters formed in-situ with
CRL and HEPES Buffer at pH 7.6
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This is further evident in Chart 2.2 which shows the rate of esterification of (S)-IBU with
different alcohols by plotting the natural logarithm of [(S)-IBU] versus time, assuming pseudo
first-order kinetics, to obtain a first-order rate constant of each alcohol. These apparent rate
constants depict that as the chain length of the alcohol increases, the rate of esterification increases
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as well, following the trend: hexanol, octanol, decanol, and dodecanol with values 9.0 x 10-4, 2.0
x 10-3, 3.9 x 10-3, and 6.4 x 10-3 hr-1, respectively. Interestingly, dodecanol had the highest % (R)IBU (~72%) and higher rate of esterification (6.4 x 10-3 hr-1).
To understand the apparent reversal in enantioselectivity between IME and longer chain
length IBU esters reacting with CRL, molecular docking studies were performed. Since a
hydrophobic pocket is present in CRL’s X-Ray crystal structure34, a Visual Representation (VR)
of each IBU ester ligand-binding site is shown in the following section.
2.5 Molecular Docking Calculations
Molecular docking is a method which predicts the preferred orientation of one molecule to
another when bound to each other.35 The preferred orientation is used to predict the Binding
Affinity (BA) between the two molecules. In this case, AutoDock Vina36 was used predict the
conformation of IBU esters to the appropriate binding site of CRL.
AutoDock Vina uses an empirical scoring function that approximates the ligand binding
free energy (ΔG). This docking function is based on electrostatic, Van der Waals, column energy,
internal ligand strain, and other energetic parameters. The scoring function of ΔG (Equation 2.1)
is calculated by six pair-wise evaluations (V) and an estimate of the conformational entropy lost
upon binding. The energetic terms include evaluations for Van Der Waals dispersion/repulsion,
hydrogen bonding, electrostatics, and solvation.37

Equation 2.1 Ligand Binding ΔG Calculated by 6 Pair-Wise Evaluations (V).37
Molecular docking calculations were done for each IBU enantiomer and ester carbon chain
length.
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2.5.1 Binding Affinity (BA) Values of (S) and (R) Enantiomers of Different IBU Esters
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From the BA values of each IBU enantiomer and ester carbon chain length shown, as the
ester carbon chain length increases, so does the BA. Also, the enantiomeric preference seems to
favor (S)-IBU binding throughout 1-11 ester carbon chain lengths, however, the preference is for
(R)-IBU binding over (S)-IBU and for (R)-IBU dodecyl ester binding over (S)-IBU dodecyl ester.
2.5.2 VR of (S)-IBU Ligand Binding to Catalytic Site of CRL (Front View)

A front view of (S)-IBU bound to CRL is shown to demonstrate that the less-polar isobutyl
group reaches inside the hydrophobic pocket instead of the more-polar trans propanoic acid group.
18

2.5.3 VR of (S)-IBU Ligand Binding to Catalytic Site of CRL (Side View)

A side view shows (S)-IBU oriented the same way in CRL with the hydrophobic pocket to
the left and the active site on the right.
2.5.4 VR of (S)-IME Ligand Binding to Catalytic Site of CRL (Side View)

(S)-IME bound to CRL also prefers to bind the isobutyl group into the hydrophobic pocket
(left side) even though the ester is less polar than the parent propanoic acid group of IBU. The
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calculated BAs are in line with the reactivity that Chavez and Mortazavi et. al.8,31 observed for the
hydrolysis of (S)-IME over (R)-IME.
2.5.5 VR of (S)-IBU Butyl Ester Ligand Binding to Catalytic Site of CRL (Side View)

Once the propanoic acid is esterified with a longer chain length alcohol (e.g. butanol), the
ester functional group prefers to bind with the hydrophobic pocket of CRL (towards the left side
of the illustration). This is evident because the hydrophobic residues (yellow) is distributed
throughout the channel and the ester is more tightly bound.

20

2.5.6 VR of (S)-IBU Decyl Ester Ligand Binding to Catalytic Site of CRL (Side View)

As the chain length gets longer (e.g. decyl ester), the ester becomes more tightly bound to
the hydrophobic pocket of CRL as given by increasing BA values. Since the hydrophobic pocket
is meant to bind fatty acids, the longer decyl group would slow down the hydrolysis of the IBU
decyl ester since the orientation is reversed from the way fatty acids should enter the hydrophobic
channel. Perhaps, the observed faster formation of longer chain IBU esters is really an indication
of a slower rate of hydrolysis as evident by the work of Chavez et. al.27 in observing that (S)-IBU
decyl ester hydrolysis is slower than (S)-IBU butyl ester.
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2.5.7 VR of (R)-IBU Dodecyl Ester Ligand Binding to Catalytic Site of CRL (Side View)

As expected, the dodecyl ester has the highest BA value due to its tight binding inside the
hydrophobic pocket which would make hydrolysis even more difficult.
2.6 Esterification Reactions of Racemic IBU, Dodecanol, and CRL
Another attempt to probe the esterification mechanism was to react racemic IBU,
dodecanol, and CRL using different equivalents of reactants, at a lower pH, and using different
CRL components as shown in Scheme 2.4.

Scheme 2.4 In-situ Esterification of Racemic IBU with Dodecanol using Different Amounts
of Reactants, Alternating pH Values, and CRL Components
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The purpose of this study was to see how altering the amount of the reactants as well as the
pH affected the conversion of (S)-IBU to (R)-IBU. These reactions were limited to dodecanol
because this alcohol seemed to produce the most ester and (R)-IBU. Because commercial CRL is
a mixture of enzymes38 and lactose, separating its components by solubility was also studied. Once
this was done, the aqueous soluble fraction reactions appeared to be more pH stable, therefore,
reactions with and without HEPES buffer were also studied.
Because of the concern that the apparent increase in (R)-IBU may be due to separation of
the hydrophobic IBU dodecyl ester, which is not accounted for in the HPLC analysis, from this
point on of the research, the reactions were sampled while they were still stirring before the
aliquots were acidified.
2.6.1 Reactions of Dodecyl IBU Ester formed in-situ with CRL by Varying the Amounts of
IBU and Dodecanol using HEPES Buffer at pH 7.6
From Chart 2.3, when the amount of racemic IBU is increased but the amount of dodecanol
is kept constant, the % of (R)-IBU produced is less. Similarly, in Chart 2.3.1, when the amount of
dodecanol is increased but the amount of racemic IBU is kept constant, the % of (R)-IBU produced
is less. These trends may indicate that as the racemic IBU or dodecanol concentrations increase,
(R)-IBU, dodecanol, or IBU dodecyl ester may be inhibiting the overall reaction. From Charts 2.4
and 2.4.1, a decrease in the rate of esterification of (S)-IBU is more pronounced by varying the
amount of racemic IBU.
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Chart 2.3 IBU Dodecyl Ester formed in-situ with CRL by Varying the Amounts of IBU
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Chart 2.3.1 IBU Dodecyl Ester formed in-situ with CRL by Varying the Amounts of
Dodecanol
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Chart 2.4 Rates of Esterification of IBU Dodecyl Ester formed in-situ with CRL by Varying
the Amounts of IBU
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Chart 2.4.1 Rates of Esterification of IBU Dodecyl Ester formed in-situ with CRL by
Varying the Amounts of Dodecanol
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2.6.2 Reactions of IBU Dodecyl Ester formed in-situ with Different Components of CRL
and HEPES Buffer at pH 7.6
Observing that commercial CRL does not completely dissolve in water, the majority of the
insolubles were separated as a pellet by centrifugation. The supernatant was further filtered
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through GeneJET Spin Columns & Collection Tubes in a centrifuge. The activity of the whole
commercial CRL, the pellets and the supernatant were measured as shown (Charts 2.5 and 2.5.1.)
Chart 2.5 IBU Dodecyl Ester formed in-situ with Different Components of CRL
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Chart 2.5.1 Rates of Esterification of IBU Dodecyl Ester formed in-situ with Different
Components of CRL
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Interestingly, the rate of esterification was greatest for the supernatant and the least for the
material in the solid pellet, although for longer times the amount of excess (R)-IBU went down.
With this observation, all further reactions were performed only with the supernatant extract. In
addition, it was observed that not as much 1 M NaOH or HCl was needed to maintain the pH of
the reactions at 7.6. In fact, in most cases the pH of the original CRL reaction had to be treated
with HCl between measurements.
2.6.3 Reactions of IBU Dodecyl Ester formed in-situ with CRL at pH 6 without HEPES
Buffer.
To test whether the esterification of (S)-IBU involves the isomerization to (R)-IBU dodecyl
ester and subsequent hydrolysis to (R)-IBU, the reaction of racemic IBU and dodecanol with CRL
was performed at pH 6 rather than 7.6. To do this, the HEPES buffer was omitted, which was now
possible because the pH did not appear to change as much using only the CRL supernatant. A
lower pH was not tested because IBU separates from water at pH 5 and below, which the basis of
the sampling of the reactions is outlined in section 2.4. A higher pH was not tested because in
aqueous organic medium, at neutral or basic pH, CRL probably assumes a less flexible
conformation39.
The first observation (Chart 2.6) was that the reaction at pH 7.6 without HEPES buffer was
9.6 times faster than with the buffer present. Second, the reaction at pH 6 was 4.3 times faster than
the reaction at pH 7.6 leading to a much more apparent formation of (R)-IBU at 6 hours as shown
in Chart 2.6.1.
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Chart 2.6 IBU Dodecyl Ester formed in-situ with CRL by Varying the pH Values
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Chart 2.6.1 Rates of Esterification of IBU Dodecyl Ester formed in-situ with CRL by
Varying the pH Values
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To test whether the apparent increase in (R)-IBU, as monitored by chiral HPLC, from the
reaction of racemic IBU with dodecanol and CRL supernatant at pH 6.0 was occurring, it was
decided that the products, ester and IBU, of these reactions needed to be isolated.
2.7 Results of the Isolation from the Reactions of Racemic IBU, Dodecanol, and CRL
without HEPES Buffer at pH 6.0
After the reactions were carried out at a mmol scale (0.206g), the whole mixture was
acidified to a pH of 5.0 and extracted with hexanes. There was a concern that not all the ester was
extracted because there was an intractable film of greasy material (dodecanol) on all the glassware.
Nevertheless, the hexanes extract was evaporated, and the remaining oil was subjected to radial
chromatography, initially eluding the ester with hexanes and then using 15% ethyl acetate/hexanes
to isolate IBU. The identity of the components was confirmed by chiral HPLC. The
chromatography fractions were evaporated to give a 45% yield (0.168g, 0.45mmol) of ester and a
48% yield (0.098g, 0.48mmol) of (R)-IBU.
From the % yields of the isolated (R)-IBU, the sampling of the previous reactions was inaccurate, probably because the IBU dodecyl ester separated from the reactions had adhered to the
glassware. Also, by gathering the aliquots from the surface or the stirring reactions, it did not
increase its recovery. In addition, isolating close to 100 % of the theoretical (R)-IBU yield indicates
that no deracemization was occurring and that the ester formed was that of (S)-IBU.
Noting that the esterification of dodecanol was better at pH 6.0 than 7.6, it was decided
that the esterification of racemic IBU with different chain length alcohols would be tested at pH
6.0.
2.8 Results of the Reactions with Racemic IBU, Different Chain Length Alcohols
(H(CH2)nOH), and CRL without HEPES Buffer at pH 6.0
As shown on the left side of Chromatograms 2.4, IBU butyl ester was formed after 2 days,
which was not observed at pH 7.6. All larger esters were formed in greater amounts in 2 days at
pH 6.0 when compared to 6 days at pH 7.6 as previously demonstrated in Chromatograms 2.3.
29

Since the IBU butyl ester was not observed at pH 7.6, the reversibility of ester formation
was tested by increasing the pH of all the primary alcohol reactions to 7.6. Surprisingly, only the
IBU butyl ester was almost completely hydrolyzed back to IBU. The other esters, chain lengths 6
to 12, did not appear to hydrolyze significantly in less than 5 days.
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Chromatograms 2.4 Reactions of Racemic IBU, Different Chain Length Primary Alcohols
(H(CH2)nOH), and CRL without HEPES Buffer at pH 6.0
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Chapter 3: Conclusions
3.1 Reaction of Racemic IBU and CRL
From the previously proposed hypothesis by Mortazavi et al.8, that deracemization of IME
occurs by the formation of an enzyme-IBU ester followed by enolization/hydrolysis, was
disproven by reacting racemic IBU under the same conditions but without DMF.
3.2 Reactions of CRL with Racemic IBU and Different Chain Length Primary Alcohols
with HEPES Buffer at pH 7.6
Under the condition previously observed for deracemization of IBU, namely pH 7.6, the
formation of IBU esters with primary alcohols was observed for chain lengths 6-12 but not 1-4 or
16.
3.3 Molecular Docking Calculations
Docking studies on IBU and IBU esters indicate that their BA for CRL increases with chain
length for (S) over (R) esters except for (R)-IBU over (S)-IBU and (R)-IBU dodecyl ester over (S)IBU dodecyl ester. Also, IBU through IBU propyl esters dock with the isobutyl group in first as
opposed to the primary alkyl group for longer chain esters.
3.4 Esterification Reactions of Racemic IBU, Dodecanol, and CRL
The reactions of CRL proceeded faster with lower concentrations of racemic IBU and
dodecanol. Also, the reactions of racemic IBU and dodecanol were more pH stable and proceeded
faster using the CRL supernatant extract compared to using the whole commercial enzyme or the
insoluble pellet from centrifugation. This indicates that the CRL enzyme is water soluble.
Esterification of racemic IBU and dodecanol proceeded two orders of magnitude faster at
pH 6 than at 7.6 and the reactions of racemic IBU and dodecanol at pH 7.6 were faster without
HEPES buffer.
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3.5 Isolation from the Reactions of Racemic IBU, Dodecanol, and CRL without HEPES
Buffer at pH 6.0
(R)-IBU was isolated in a 48 % yield from the reactions of racemic IBU and dodecanol at
pH 6.0. This along with the observation that reactions were faster at pH 6 versus 7.6, indicates that
the observed esterifications do not involve deracemization of IBU but instead were the preference
for formation of longer chain length esters that separated from solution.
3.6 Reactions with Racemic IBU, Different Chain Length Primary Alcohols, and CRL
without HEPES Buffer at pH 6.0
(S)-IBU butyl ester could be formed at pH 6.0 in 2 days and hydrolyzed almost completely
at pH 7.6 over 5 days whereas larger esters did not hydrolyze reversibly over the same time. This
indicates that the faster rate of formation of longer chain esters is probably an indication of a higher
rate of hydrolysis of shorter chain esters at pH 7.6.
3.7 Potential Health Problems with the Use of Racemic IBU
Racemic IBU esters have been reported to cause gastrointestinal problems such as ulcers,
bleeding, irritation, and inflammation even more so than IBU.40,41,42 This work shows that long
chain primary alcohols can be used to esterify (S)-IBU with CRL although they are difficult to
hydrolyze, which could be a health concern not only because of the previously reported problems
with IBU esters, but also because these type of intractable esters may be formed and accumulated
in the human body.
A working hypothesis of why longer chain (S)-IBU esters are difficult to hydrolyze is
shown in Scheme 3.1. If, like a fatty acid, (S)-IBU enters the CRL hydrophobic pocket with the
isobutyl chain first, forms an enzyme ester with the serine of the active site, is trans-esterified to a
long chain (S)-IBU ester, and the long chain alkyl group binds strongly to the hydrophobic pocket
as indicated in the docking studies of Section 2.5, then the hydrolysis of long chain (S)-IBU esters
would be disfavored because of hydrophobic anchoring.
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Scheme 3.1: Esterification Reaction Scheme of (S)-IBU with Long Chain Length Alcohols
and the Hydrophobic Anchoring of Long Chain (S)-IBU Esters
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3.8 Resolution of Racemic IBU by Reversible Esterification of (S)-IBU with Butanol and
CRL in Water, a Potential Green Chemistry Application
Since lipase catalyzes several biotransformations,43,44,45 the reactions presented in this
thesis are the basis of metabolism of all living organisms involving a carboxyl group that reacts
via esterification, transesterification, and hydrolysis.46,47,48 Most of these reactions consist of an
alcohol and a carboxylic acid in the presence of organic non-polar solvents.49,50,51,52 However, the
use of polar solvents, e.g. water, was shown in this work to be technically feasible and offers
significant cost savings. Furthermore, the absence of non-polar solvents makes the process
environmentally friendly, since most non-polar solvents are toxic and polluting agents.53
The present work evaluates the performance of CRL for the esterification of butanol with
IBU as well as longer chain length primary alcohols (e.g. hexyl, octyl, decyl, and dodecyl) in a
polar solvent system. Experimental runs were carried out to analyze the influence of alcohol chain
length (C4 to C12) and IBU concentration on the esterification yield and productivity. The results
allowed a better understanding of the pH influence in this environmentally friendly process of
producing ester at a lower pH (6.0) and hydrolyzing ester at a higher pH (7.6). This microscopic
reversibility also has the advantage of a higher productivity when compared with a non-polar
solvent system.54
It is also interesting to speculate that as observed with CRL, a pH of 6 favors the formation
of (S)-IBU butyl ester raising the pH, and a pH of 7.6 favors the hydrolysis of this ester lowering
the pH, as would be expected by Le Chatelier’s Principle as outlined in Scheme 3.2. Since the
introduction of carbon dioxide and other acid producing pollutants are acidifying the environment,
perhaps obesity or the accumulation of fat catalyzed by lipase is a way for nature to counter this
effect.

Scheme 3.2 The pH Dependency of CRL to Esterify at Low pH and Hydrolyze at High pH.
35

Chapter 4: Experimental
4.1 Materials
Candida rugosa lipase (CRL, 1176 units/mg of solid), 4-(2-hydroxyethyl)-1piperazineethanesulfonic acid (HEPES), hexanes (98.5% CHROMASOLV), ethyl acetate,
methanol, ethanol, butanol, 2-propanol, propanol, hexanol, octanol, decanol, dodecanol, and
hexadecanol were purchased from the Sigma-Aldrich Chemical Company. Racemic IBU
(200mg/tablet) was isolated from inexpensive commercial tablets purchased from Sam’s Club. All
other chemicals and analytical grade reagents were from commercial sources and were used
without further purification.
4.2 Equipment
4.2.1 Solvent Evaporation
An IKA™ RV 10 rotary evaporator was utilized to remove volatile organic solvents from
different reaction mixtures (Figure 4.2.1).

Figure 4.2.1 Rotary Evaporator for Removing Organic Solvents
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4.2.2 Chiral Column High Performance Chromatography
A Chiralcel OJ chiral column (Diacel Chemical Industries) High Performance Liquid
Chromatography (HPLC) with a Spectra Physics: Spectra System P1500 gradient pump and a
Milton Roy UV detector set at 256 nm (Figure 4.2.2) programmed with Netbeans® and Java®
software were employed to quantify, identify, and monitor all analyses at room temperature. The
chiral column is efficient of resolving IBU and IBU esters with a mobile phase of hexanes/2propanol (97/3, v/v), a flow rate of 1 mL/min, and helium solvent degassing. Analytes of 5.0-10.0
µL were introduced into the pump injector at room temperature (22oC).

Figure 4.2.2 HPLC Equipment and Software Used for the Analysis of IBU Esters.
4.2.3 pH Measurements
An Oakton bench pH/Ion Meter (pH 1100 series) was used to measure the pH of buffered
solutions and of the reaction mixtures before and after adding the lipase (Figure 4.2.3).

Figure 4.2.3 pH/Ion Meter for Measuring the pH of Buffer Solutions.
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4.2.4 Centrifugation
Separations of CRL extracts were done with a Fisher Scientific: Safety Centrifuge (Figure
4.2.4) using GeneJET Spin Columns & Collection Tubes (50 units).

Figure 4.2.4 Safety Centrifuge with GeneJET Spin Columns & Collection Tubes.
4.2.5 Nuclear Magnetic Resonance (NMR) Spectrometry
Proton Nuclear Magnetic Resonance (1H NMR) and carbon-13 (13C) NMR spectra of
crude reagents and isolated products were recorded on a Bruker-Spectrospin 300 MHz
spectrometer (Figure 4.2.5) with deuterated chloroform (CDCl3) as the solvent and
tetramethylsilane (0.03% v/v) as an internal standard.
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Figure 4.2.5 Bruker-Spectrospin 300 MHz Nuclear Magnetic Resonance Spectrometer.
4.2.6 Horizontal Bulb to Bulb Distillation
A Kuelgrohr apparatus (Sigma Aldrich Chemical Company, Inc.) was used to purify
compounds after rotary evaporation by distillation at higher vacuum and by removal of high
boiling point solvents. An ice water bath was used to trap distillates in the bulb and liquid nitrogen
was used to trap volatiles before the vacuum pump (Figure 4.2.6).

Figure 4.2.6 Kuelgrohr Horizontal Distillation for Purifying Compounds
39

4.2.7 Radial Chromatography
A Chromatotron 7924 T (Figure 4.2.7) with silica gel plate (4 mm thickness) and a mobile
phase of 100% hexanes was used to moisten the plate and to separate the IBU esters from racemic
IBU. An aliquot of the sample (~1 g) was introduced into the sorbent rotor silica plate as it rotated.
A UV lamp was utilized to observe the bands as they eluded from the center to the outside of the
plate. Afterward a final wash with methanol of the plate was performed to remove impurities.

Figure 4.2.7 Chromatotron 7924 T for Separating Compounds
4.2.8 Heating and Stirring
Heating wells of various sizes filled with sand along with electrical variable
autotransformers (0-140 V, 10 A, 50/60 Hz) were utilized as heating source to warm up all the
reactions to 40 °C. Various types of magnetic stirrers were used to mix all the reactions while
heating. The reaction setups with sand bath heating sources are illustrated in Figure 4.2.8.
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Figure 4.2.8 Reaction Setups of the Experiment with Variations of Alcohol and IBU.
4.2.9 Mass Measurements
A Sartorius Basic balance (Figure 4.2.9) with up to 4-digit accuracy was utilized for all
mass measurements.

Figure 4.2.9 Sartorius Balance
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4.3 Experimental
4.3.1 Racemic IBU Extraction from Tablets
Isolation of racemic IBU from commercial tablets (200 mg/tablet) was done (Figure 4.3.1)
by suspending twenty tablets in 100 mL acetone for 30 minutes (5 mL/tablet) inside a clean and
dry 125 mL beaker. Vacuum filtration was done to separate the coating and the filler from the
filtrate containing the dissolved racemic IBU in acetone. The solvent was removed by vacuum
distillation on the rotary evaporator, and the remaining white powder was used for the subsequent
reactions listed below.

Figure 4.3.1 Extraction and Filtration from IBU Tablets.
4.3.2 Reaction of Racemic IBU and CRL
To a clean and dry 25mL round bottom flask was added 206.3mg of racemic IBU, 0.9g of
CRL, 1.19g of HEPES buffer, and 10mL of H2O. The initial pH of the solution was ~6.0 and was
adjusted by adding 1M NaOH (~10mL) into the solution. Once the solution reached the optimal
pH of 7.6, the reaction flask was covered with a plastic stopper and placed into a heating well filled
with sand. A variable transformer and an alcohol thermometer were used to maintain the
temperature at 40oC for 72 hours. The reaction was monitored via chiral column HPLC analysis
by taking aliquots of the reaction and acidifying it to a pH ~5.0 with 1M HCl followed by extraction
with hexanes. 10µL of the organic layer was injected into the chiral column HPLC for analysis of
IBU.
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4.3.3 Reaction of Racemic IBU, Methanol, and CRL
To a clean and dry 25mL round bottom flask was added 206.3mg of racemic IBU, 0.9g of
CRL, 1.19g of HEPES buffer, 40.5µL of methanol and 10mL of H2O. The initial pH of the solution
was ~5.0 and was adjusted by adding 1M NaOH dropwise (~10mL) into the solution. Once the
solution reached the optimal pH of 7.6, the reaction flask was covered with a plastic stopper and
placed into a heating well filled with sand. A variable transformer and an alcohol thermometer
were used to maintain the temperature at 40oC for 72 hours. The reaction was monitored via chiral
column HPLC analysis by taking aliquots of the reaction and acidifying it to a pH ~5.0 with 1M
HCl followed by extraction with hexanes. 10µL of the organic layer were injected into the chiral
column HPLC for analysis of IBU.
4.3.4 Reactions of Racemic IBU, Different Chain Length Alcohols, and CRL with HEPES
buffer at pH 7.6
To clean and dry 25mL round bottom flasks were added 206.3mg of racemic IBU, 0.9g of
CRL, 1.19g of HEPES buffer, 1 mmol of each alcohol (methanol, ethanol, propanol, etc.) and
10mL of H2O. The initial pH of the solutions was ~5.0 and were adjusted by adding 1M NaOH
dropwise (~10mL) into the solutions. Once the solutions reached the optimal pH of 7.6, the
reaction flasks were covered with plastic stoppers and placed into heating wells filled with sand.
Variable transformers and alcohol thermometers were used to maintain the temperature at 40oC
for ~200 hours. The reactions were monitored via chiral column HPLC analysis by taking aliquots
of the reactions and acidifying them to a pH ~5.0 with 1M HCl followed by extraction with
hexanes. 10µL of the organic layers were injected into the chiral column HPLC for analysis of
IBU esters.
4.3.5 Reactions of IBU Dodecyl Ester formed in-situ with CRL by Varying the Amounts of
IBU and Dodecanol with HEPES buffer at pH 7.6
To clean and dry 25mL round bottom flasks were added alternating 0.5/ 1.0/ 2.0 mmol
amounts of racemic IBU, 0.9g of CRL, 1.19g of HEPES buffer, alternating 0.5/ 1.0/ 2.0/ mmol
amounts of dodecanol and 10mL of H2O. The initial pH of the solutions was ~5.0 and were
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adjusted by adding 1M NaOH dropwise (~10mL) into the solutions. Once the solutions reached
the optimal pH of 7.6, the reaction flasks were covered with plastic stoppers and placed into heating
wells filled with sand. Variable transformers and alcohol thermometers were used to maintain the
temperature at 40oC for ~200 hours. The reactions were monitored via chiral column HPLC
analysis by taking aliquots of the reactions and acidifying them to a pH ~5.0 with 1M HCl followed
by extraction with hexanes. 10µL of the organic layers were injected into the chiral column HPLC
for analysis of IBU esters.
4.3.6 Reactions of IBU Dodecyl Ester formed in-situ with Different Components of CRL
and HEPES buffer at pH 7.6
To clean and dry 25mL round bottom flasks were added 0.5 mmol of racemic IBU, 0.9g of
CRL (crude)/ 10mL of CRL (supernate)/ 0.3g of CRL (pellet), 1.19g of HEPES buffer, 0.5 mmol
of dodecanol and 10mL of H2O. The initial pH of the solutions was ~5.0/ ~6.0/ ~5.0, respective of
each component, and were adjusted by adding 1M NaOH dropwise (~10mL) into the solutions.
Once the solutions reached the optimal pH of 7.6, the reaction flasks were covered with plastic
stoppers and placed into heating wells filled with sand. Variable transformers and alcohol
thermometers were used to maintain the temperature at 40oC for ~200 hours. The reactions were
monitored via chiral column HPLC analysis by taking aliquots of the reactions and acidifying them
to a pH ~5.0 with 1M HCl followed by extraction with hexanes. 10µL of the organic layers were
injected into the chiral column HPLC for analysis of IBU esters.
4.3.7 Reactions of IBU Dodecyl Ester and CRL formed in-situ without HEPES Buffer by
Varying the pH Values
To clean and dry 25mL round bottom flasks were added 1.0 mmol of racemic IBU, 20mL
of CRL supernatant and 1.0 mmol of dodecanol. The initial pH of the solutions was ~6.0 and one
of them was adjusted by adding 1M NaOH dropwise (~5mL) into the solution. Once the solution
reached the optimal pH of 7.6, the reaction flasks were covered with plastic stoppers and placed
into heating wells filled with sand. Variable transformers and alcohol thermometers were used to
maintain the temperature at 40oC for ~12 hours. The reactions were monitored via chiral column
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HPLC analysis by taking aliquots of the reactions and acidifying them to a pH ~5.0 with 1M HCl
followed by extraction with hexanes. 10µL of the organic layers were injected into the chiral
column HPLC for analysis of IBU esters
4.3.8 Reactions of Racemic IBU, Different Chain Length Alcohols, and CRL without
HEPES buffer at pH 6.0
To clean and dry 25mL round bottom flasks were added 206.3mg of racemic IBU, 20mL
of CRL supernatant and 1 mmol of each alcohol (methanol, ethanol, propanol, etc.). The initial pH
of the solutions was ~6.0 and the reaction flasks were covered with plastic stoppers and placed
into heating wells filled with sand. Variable transformers and alcohol thermometers were used to
maintain the temperature at 40oC for ~72 hours. Afterwards, they were adjusted by adding 1M
NaOH dropwise (~5mL) into the solutions until they reached the optimal pH of 7.6. The reactions
were monitored via chiral column HPLC analysis by taking aliquots of the reactions and acidifying
them to a pH ~5.0 with 1M HCl followed by extraction with hexanes. 10µL of the organic layers
were injected into the chiral column HPLC for analysis of IBU esters.
4.3.8 Molecular Docking Calculation Parameters
Ligand coordinate pdb files were generated with an Online SMILES Translator and
Structure File Generator (https://cactus.nci.nih.gov/translate/) of (S/R)-IBU and each (S/R)-IBU
ester (methyl to dodecyl) created in ChemDraw Prime 16.0 sdf files. A protein coordinate pdb file
was obtained from the Protein Data Bank (www.pdb.org) website with the pdb ID: 3RAR. In the
Autodock Vina: Tools program, appropriate hydrogen atoms were added to the ligand and protein
structures with the subtraction of water molecules and current ligands (CA, IAN, NAG) found in
3RAR’s structure. The rotatable bonds were fixed to non-rotatable on each ligand’s aliphatic ester
carbons and were all saved as pdbqt files for further calculations. The grid box coordinate
dimension/size were: center X = 70, center Y = 54, center Z = -21, size X = 40, size Y = 40, and
size Z = 40 with a 1Å spacing. The calculations generated output files of each (S/R)-IBU ester
ligand binding site which were then analyzed with the PyMOL 2.3.0 program.
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Appendix

Figure 1. Proton 1HNMR Spectrum of (S)-IBU Dodecyl Ester
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Figure 2. Carbon-13 NMR Spectrum of (S)-IBU Dodecyl Ester
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